Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
J. J. Miceli
Observed names:
J J Miceli,
J MICELI,
J Miceli,
J. Miceli,
J.J. Miceli,
Jeff Miceli
show all 6
Institution:
Pfizer (United States)
Observed institutions:
Boston University,
Cincinnati Children's Hospital Medical Center,
University of Connecticut,
Pfizer (United States),
Wayne State University,
Eunice Kennedy Shriver Center,
Children's Hospital of Michigan
show all 7
OpenAlex ID:
A5111859786
Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions
2000
·
C. Prakash
, A. Kamel
, et al.
·
British Journal of Clinical Pharmacology
·
131
PDF
The effect of carbamazepine on the steady‐state pharmacokinetics of ziprasidone in healthy volunteers
2000
·
J. J. Miceli
, R. J. Anziano
, et al.
·
British Journal of Clinical Pharmacology
·
96
Single‐ and multiple‐dose pharmacokinetics of ziprasidone under non‐fasting conditions in healthy male volunteers
2000
·
J. J. Miceli
, K. D. Wilner
, et al.
·
British Journal of Clinical Pharmacology
·
87
PDF
Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study
2008
·
E. Vieta
, T. Ramey
, et al.
·
Journal of Psychopharmacology
·
80
The effects of ketoconazole on ziprasidone pharmacokinetics —a placebo‐controlled crossover study in healthy volunteers
2000
·
J. J. Miceli
, M. Smith
, et al.
·
British Journal of Clinical Pharmacology
·
76
PDF
An 8-Week, Randomized, Phase 2, Double-Blind, Sequential Parallel-Group Comparison Study of Two Dose Levels of the GABAA Positive Allosteric Modulator PF-06372865 Compared With Placebo as an Adjunctive Treatment in Outpatients With Inadequate Response to Standard of Care for Generalized Anxiety Disorder
2018
·
Arthur Simen
, Mark Whitlock
, et al.
·
Journal of Clinical Psychopharmacology
·
28
Tissue distribution and elimination kinetics of poly-brominated biphenyls (PBB) from rat tissue
1981
·
J MICELI
, B MARKS
·
Toxicology Letters
·
22
Bioavailability Studies of Drugs with Nonlinear Pharmacokinetics: II. Absolute Bioavailability of Intravenous Phenytoin Prodrug at Therapeutic Phenytoin Serum Concentrations Determined by Double‐Stable Isotope Technique
1993
·
T. R. Browne
, G. K. Szabo
, et al.
·
The Journal of Clinical Pharmacology
·
21
Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
1998
·
C Prakash
, D Cui
, et al.
·
PubMed
·
12
The pharmacokinetics of CP-88,059 in healthy male volunteers following oral and intravenous administration
1994
·
J. Miceli
, Thomas L. Hunt
, et al.
·
Clinical Pharmacology & Therapeutics
·
10
Pharmacokinetic bases for the treatment of phencyclidine (PCP) intoxication.
1979
·
A Done
, R Aronow
, et al.
·
PubMed
·
8
Characterization of the intramuscular pharmacokinetics of ziprasidone in schizophrenic patients
1998
·
J. Miceli
, S. Preskorn
, et al.
·
European Psychiatry
·
5
PDF
Pharmacokinetics and dynamics of furosemide in the newborn piglet.
1990
·
J J Miceli
, P A Kramer
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
5
Anxiolytic effects of ziprasidone compared with diazepam and placebo prior to dental surgery
1996
·
K.D. Wilner
, R.J. Anziano
, et al.
·
European Neuropsychopharmacology
·
4
P.4.a.015 Adjunctive pregabalin after partial response to SSRI or SNRI in GAD: results of a double-blind, placebo-controlled trial
2009
·
J. Weaver
, J. Miceli
, et al.
·
European Neuropsychopharmacology
·
3
Effects of oral ziprasidone and haloperidol on QTC at clinical and high doses
2003
·
J. Miceli
, T. Shiovitz
, et al.
·
Schizophrenia Research
·
3
The population pharmacokinetics of intramuscular ziprasidone in healthy and schizophrenic subjects
1998
·
T. Tensfeld
, J. Miceli
, et al.
·
European Neuropsychopharmacology
·
3
Pharmacokinetics of intramuscular ziprasidone in schizophrenic patients: Population pharmacokinetic modelling
1998
·
J. Miceli
, K. Wilner
, et al.
·
European Neuropsychopharmacology
·
3
Use of population pharmacokinetic modeling to characterize intramuscular pharmacokinetics for ziprasidone in schizophrenic patients
1999
·
M SHAD
, S PRESKORN
, et al.
·
Clinical Pharmacology & Therapeutics
·
2
Ziprasidone metabolism and cytochrome P450 isoforms
1997
·
C. Prakash
, A. Kamel
, et al.
·
Biological Psychiatry
·
2
Single and multiple dose pharmacokinetics of ziprasidone in healthy males
1996
·
K.D. Wilner
, R.A. Hansen
, et al.
·
European Neuropsychopharmacology
·
2
Single and multiple dose pharmacokinetics of ziprasidone in healthy males
1996
·
K.P. Wilner
, R.A. Hansen
, et al.
·
European Psychiatry
·
2
A Randomized, Double-blind, 6-week, Dose-ranging Study of Pregabalin in Subjects With Restless Legs Syndrome
2009
·
R. Allen
, C. Chen
, et al.
·
Sleep Medicine
·
1
Lack of drug interactions with ziprasidone: An overview
1999
·
J. Miceli
, T. Tensfeldt
, et al.
·
European Neuropsychopharmacology
·
1
Anxiolytic effects of ziprasidone, an atypical antipsychotic, compared with diazepam and placebo on subjects prior to undergoing minor dental surgery.
1996
·
K.D. Wilner
, A.C. Johnson
, et al.
·
Clinical Pharmacology & Therapeutics
·
1
Show more works
View as search
Works count:
33
Citation count:
609
H-index:
10
I10-index:
10
Year
Topic
Type